Palliative chemotherapy (2nd line) with imatinib (Glivec) in patients with bile duct cancer
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Imatinib (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- Acronyms GlivecGG
- 02 Sep 2009 Status changed from not stated to discontinued as reported by ISRCTN: Current Controlled Trials.
- 10 Nov 2006 New trial record.